Efficacy and Safety of Apixaban in COVID-19 Coagulopathy Patients With Respiratory Severity Under Critical Care
Clinical trial NCT05088928 · UNKNOWN
Trial details
- NCT number
- NCT05088928
- Sponsor
- Scotmann Pharmaceuticals
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-01
- Primary completion
- 2022-05-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.